COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donald Cutlip, MD
Executive Director, Clinical Investigation, Harvard Clinical Research Institute
Principal InvestigatorKOL profile → - Sigmund Sliber, MD
Professor of Medicine at The University of Munich
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinique Axium
Aix-en-Provence, France
- Hopital Henri Duffaut
Avignon, France
- Albert Schweitzer Hospital
Colmar, France
- Clinique Du Diaconat
Mulhouse, France
- Centre Hospitalier de Pau
Pau, France
- Clinique St. Hilaire
Rouen, France
- Sankt Kathatinen Hospital
Frankfurt, Germany
- Kardiologische Praxis Und Praxisklinik
München, Germany
- Paul Stradins Clinical University Hospital
Riga, Latvia
- Clinical Center of Serbia
Belgrade, Serbia
- Hospital de la Santa Creu
Barcelona, Spain
- Hospital Clinico San Carlos
Madrid, Spain
- Kantonsspital St. Gallen
Sankt Gallen, Switzerland
- Bakersfield Memorial Hospital
Bakersfield, California, United States
- Mt Sinai Medical Center
Miami Beach, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Heart Center of Indiana
Indianapolis, Indiana, United States
- Louisiana Heart Hospital
Lacombe, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Deborah Heart & Lung Center
Browns Mills, New Jersey, United States
- St Joseph'S Hospital
Liverpool, New York, United States
- Lenox Hill Hospital
New York, New York, United States
- Mount Sinai Hospital
New York, New York, United States
- Oklahoma Foundation for Cardiovascular Research
Oklahoma City, Oklahoma, United States
- Southern Oregon Cardiology
Medford, Oregon, United States
- York General Hospital
York, Pennsylvania, United States
- Cardiology Consultants of Texas
Dallas, Texas, United States
- Plaza Medical Center
Fort Worth, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
- Texas Cardiac Center
Lubbock, Texas, United States
- the Heart Hospital Baylor Plano
Plano, Texas, United States
- San Antonio Endovascular & Heart Institute
San Antonio, Texas, United States
- Tyler Cardiovascular Consultants
Tyler, Texas, United States
- Virginia Cardiovascular Specialists
Richmond, Virginia, United States
- Aspirus Heart & Vascular Institute
Wausau, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Aug 2013
- Primary completion
- 30 Nov 2015
- Completion
- 2 Mar 2020
- Last update posted
- 22 Dec 2021
- Registered enrollment
- 296
- Registry id
- NCT01925794
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.